They issued shares once and raise $250 million.. Now they have the cash they need to launch their drug.. INSY is strangely not a marijuana company despite the hype that it is.. Take a look at there most recent annual report.. Of $30 mil in R&D only $5 mil was spent on marijuana related CBD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.